Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert Steven Siegel is active.

Publication


Featured researches published by Robert Steven Siegel.


Biochemical and Biophysical Research Communications | 1992

High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid β-protein precursor

Steven L. Wagner; Robert Steven Siegel; Thomas S. Vedvick; William C. Raschke; William E. Van Nostrand

The protease inhibitor, protease nexin-2 (PN-2), is the secreted isoform of the Alzheimers amyloid β-protein precursor (AβPP) that contains the Kunitz-type protease inhibitor (KPI) domain. Here we describe the use of the methylotrophic industrial yeast Pichia pastoris as a host system for the large scale production of the KPI domain of PN-2AβPP. In addition to the 57 amino acid KPI domain, the expression product contained an additional four amino acid residues at its amino terminus that correspond to amino acids 285–288 of AβPP (Ponte et al. 1988 Nature 311:525–527). This expression system generated yields of greater than 1.0 gram of KPI domain per liter of fermentation media. The secreted 61 amino acid product was purified to homogeneity and biochemically characterized. Amino acid analysis and sequencing of the entire expressed KPI domain verified its integrity. Similar to native PN-2AβPP, the purified KPI domain potently inhibited trypsin, chymotrypsin, and coagulation factor XIa. Although heparin augments the inhibition of factor XIa by native PN-2AβPP it had no effect on the inhibition of factor XIa by expressed KPI domain suggesting that heparin binds to regions on native PN-2AβPP outside of the protease inhibitory domain. This KPI domain expression product should be useful in studying the physiologic and pathophysiologic functions of PN-2AβPP.


Biochimica et Biophysica Acta | 1994

Expression, purification, and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid β-protein precursor-like protein-2

William E. Van Nostrand; Alvin H. Schmaier; Barry R. Neiditch; Robert Steven Siegel; William C. Raschke; Sangram S. Sisodia; Steven L. Wagner

In this report we describe the use of the methylotrophic industrial yeast Pichia pastoris as a host system for the large scale production of the Kunitz-type proteinase inhibitor (KPI) domain of the amyloid beta-protein precursor-like protein-2 (APLP-2). The expression plasmid for the KPI domain of APLP-2 encoded amino acids 305-364 of the APLP-2 cDNA (Slunt et al. (1994) J. Biol. Chem. 269, 2637-2644). The secreted 60 amino-acid product was purified to homogeneity and biochemically characterized. Amino-acid sequencing of the expressed KPI domain of APLP-2 verified its integrity. The proteinase inhibitory properties of the KPI domain of APLP-2 were compared to those of the KPI domain of proteinase nexin-2/amyloid beta-protein precursor (PN-2/A beta PP). Both KPI domains potently inhibited trypsin and, to a lesser extent, chymotrypsin, plasmin, and coagulation factors XIa and IXa. However, the KPI domain of APLP-2 was a approximately 20-fold less effective inhibitor of coagulation factor XIa compared to the KPI domain of PN-2/A beta PP. Similarly, the KPI domain of APLP-2 was a less effective anticoagulant in coagulation based assays than the KPI domain of PN-2/A beta PP. These studies indicate that the KPI domains of PN-2/A beta PP and APLP-2 form a family of proteinase inhibitors although the former is a better inhibitor of factor XIa and a more potent anticoagulant than the latter.


Amyloid | 1996

Specific patterns of amyloid β-protein precursor isoform secretion and proteolysis in cultured human cells

Blake Alan Rowe; Robert Steven Siegel; Michael F Murphy; Thomas S. Vedvick; Steven L. Wagner

A characteristic neuropathologic feature of Alzheimer c disease is an abundance of brain-localized neuritic plaques. These plaques are identified as areas of degenerating nerve terminals surrounding cores of aggregated and insoluble fibrils of amyloid β-protein (Aβ). Aβ is generated by proteolytic cleavage of a large precursor protein, the amyloid β-protein precursor (AβPP). In this study, soluble AβPPs (sAβPPs) secreted by human cell lines originating from different tissues were characterized. Various human cell types were shown to secrete different characteristic isoforms of AβPP. Peripheral cells (i.e., fibroblasts and keratinocytes) secreted only the soluble derivative of the 770-amino acid isoform (sAβPP770). In contrast, cells derived from the central and peripheral nervous system (i.e., neumblastoma and glioblastoma) secreted the soluble derivative of the 751-amino acid isoform (sAβPP751), while the 695-amino acid isoform (sAβPP695) was secreted exclusively by neuronal-type cells. We have also dete...


Annals of the New York Academy of Sciences | 1990

Fermentation development of recombinant Pichia pastoris expressing the heterologous gene : bovine lysozyme

Russell Arthur Brierley; Christopher Michael Bussineau; R. Kosson; A. Melton; Robert Steven Siegel


Journal of Industrial Microbiology & Biotechnology | 1991

High-level secretion of biologically active aprotinin from the yeast Pichia pastoris.

Thomas S. Vedvick; Richard Gordon Buckholz; Michael E. Engel; Mary Susan Urcan; Jennifer Anne Kinney; Sally Provow; Robert Steven Siegel; Gregory Patrick Thill


Archive | 1989

Mixed feed recombinant yeast fermentation

Russell Arthur Brierley; Robert Steven Siegel; Christopher Michael Bussineau; William Scot Craig; Gregory Clyde Holtz; Geneva Ruth Davis; Richard Gordon Buckholz; Gregory Patrick Thill; Lillian Margaret Wondrack; Mary Ellen Digan; Michael Miller Harpold; Stephen V Lair; Steven B. Ellis; Mark E. Williams


Archive | 1989

Purification of hepatitis proteins

William Scot Craig; Robert Steven Siegel


Archive | 1990

Production of epidermal growth factor in methylotrophic yeast cells

Robert Steven Siegel; Richard Gordon Buckholz; Gregory Patrick Thill; Lillian Margaret Wondrack


Archive | 1989

PRODUCTION OF EPIDERAMAL GROWTH FACTOR IN PICHIA PASTORIS YEAST CELLS

Robert Steven Siegel; Richard Gordon Buckholz; Gregory Patrick Thill; Lillian Margaret Wondrack


Archive | 1992

Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states

Steven L. Wagner; Robert Steven Siegel; Gregory Patrick Thill; Michael Miller Harpold; William T. Comer

Collaboration


Dive into the Robert Steven Siegel's collaboration.

Top Co-Authors

Avatar

Gregory Patrick Thill

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar

Lillian Margaret Wondrack

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar

William Scot Craig

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar

Richard Gordon Buckholz

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar

Michael Miller Harpold

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar

Russell Arthur Brierley

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christopher Michael Bussineau

Salk Institute for Biological Studies

View shared research outputs
Researchain Logo
Decentralizing Knowledge